Key facts
- Notable investors include Korea Investment Partners, iAccel (Seongnam-si).
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Solsion Biomedical
- ·The full record, as it builds
Funding rounds
No funding rounds for Solsion Biomedical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Solsion Biomedical
Provider of professional technical services intended to support business project development and advisory activities. The company offers research and development services for manufacturing implantable medical devices for skin beauty and subcutaneous tissue reconstruction based on biocompatible polymers PLA and HA, enabling organisational clients to access technical advice, ongoing support, and project execution assistance.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2016
- Website
- solsion.com/
- Ownership
- Privately Held (backing)
Solsion Biomedical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Solsion Biomedical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Solsion Biomedical in its N-PORT filings yet. We sweep new filings monthly.